Crowdonomics
WatchlistPortfolio
This isn’t CANCERVAX’s most recent raise. Reg CF · Common Stock · Jun 2026 (Open) is more current.View latest round
CANCERVAX

Reg CF · Common Stock · Jun 2025

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$903.1K / $1.2M max
73% of ceiling
Investors
693
$1.6K avg
Post-money valuation
$101.1M
pre-money + amount raised

Financials disclosed in this offering

FY2023–FY2024 · hover for source
$0
−$3.4M
FY2023
$0
−$4.4M
FY2024
RevenueNet income
Metric
FY2023 audited
FY2024 audited
Income statement
Revenue
$0
$0
Cost of goods sold
$3,418,574
$0
Net income
-$3,418,574
-$4,387,678
Taxes paid
$0
$0
Balance sheet
Cash
$138,209
$183,505
Accounts receivable
$0
$0
Total assets
$205,942
$299,444
Short-term debt
$1,684,944
$3,421,147
Long-term debt
$0
$0
Total liabilities
$1,684,944
$3,421,147
Other
Headcount
—
6

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

4 amendments
  1. Feb 20, 2026
    • Deadline Mar 13, 2026 → Apr 30, 2026

    “Campaign Extending to April 30 2026”

    Form C/A on EDGAR ↗
  2. Jan 7, 2026
    • Deadline Jan 12, 2026 → Mar 13, 2026

    “Campaign is Extending to March 13 2026”

    Form C/A on EDGAR ↗
  3. Nov 6, 2025
    • Deadline Nov 10, 2025 → Jan 12, 2026

    “Offering end date is being extended to January 12, 2026.”

    Form C/A on EDGAR ↗
  4. Aug 28, 2025
    • Deadline Sep 1, 2025 → Nov 10, 2025

    “Issuer is extending their offering end date to November 10, 2025.”

    Form C/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. The quoted reason is the issuer’s own statement from the Form C/A.

Deal terms

Pre-money$100M
Post-money$101.1M
Price / share$2.10
Shares offered4,761

Perks

Early Bird 1: $525+ · 10% bonus shares · until Jun 15, 202510% bonus$525+
Early Bird 2: $1,000+ · 12% bonus shares · until Jun 15, 202512% bonus$1K+
Early Bird 3: $5,000+ · 15% bonus shares · until Jun 15, 202515% bonus$5K+
Early Bird 4: $10,000+ · 20% bonus shares · until Jun 15, 202520% bonus$10K+
Early Bird 5: $25,000+ · 25% bonus shares · until Jun 15, 202525% bonus$25K+
Early Bird 6: $50,000+ · 30% bonus shares · until Jun 15, 202530% bonus$50K+
Flash Perk 1: $2,500+ · 8% bonus shares · Jul 6, 2025 – Jul 11, 20258% bonus$2.5K+
Flash Perk 2: $2,500+ · 8% bonus shares · Jul 31, 2025 – Aug 5, 20258% bonus$2.5K+

Offering details

Target$9,998
Max$1,235,000
Min investment—
OpenedJun 2, 2025
DeadlineApr 30, 2026
ClosedApr 30, 2026
Days active332

Links & provenance

Campaign pagePitch videoSEC filing
Source: SEC EDGAR
0001665160-25-001164
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.